» Articles » PMID: 31594301

Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic Antitumor Therapy

Overview
Journal Nano Lett
Specialty Biotechnology
Date 2019 Oct 10
PMID 31594301
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Nanoscale photodynamic therapy (PDT) is an appealing antitumor modality for which apoptosis is the major mechanism of toxicity induction. It was postulated that the highly reactive singlet oxygen in PDT could deplete glutathione (GSH) and activate ferroptosis, the extent to which could be further manipulated by a redox-responsive nanocarrier. To validate this, a disulfide-bearing imidazole ligand coordinated with zinc to form an all-active metal organic framework (MOF) nanocarrier where a photosensitizer (chlorin e6/Ce6) was encapsulated. Regardless of light irradiation, the Ce6-loaded nanocarrier caused the depletion of intracellular GSH via the disulfide-thiol exchange reaction in a murine mammary carcinoma cell line (4T1). The GSH depletion further caused the inactivation of glutathione peroxide 4 (GPX4) and the enhancement of cytotoxicity that was alleviated by ferroptosis inhibitors. The superior antitumor efficacy of the all-active nanocarrier was corroborated in a 4T1 tumor-bearing mice model regarding tumor growth suppression and animal survival rate. The coadministration of an iron chelator weakened the antitumor potency of the nanocarrier due to ferroptosis inhibition, which was supported by the fact of tumor growth upsurge and the recovered GPX4 activity. The current work highlights the contribution of ferroptotic machinery to antitumor PDT via an activatable, adaptable, all-active MOF nanocarrier.

Citing Articles

Recent Advances in Glutathione Depletion-Enhanced Porphyrin-Based nMOFs for Photodynamic Therapy.

Gong B, Zhang Q, Chen J, Qu Y, Luo X, Wang W Pharmaceutics. 2025; 17(2).

PMID: 40006611 PMC: 11860060. DOI: 10.3390/pharmaceutics17020244.


Copper-based metal-organic frameworks for antitumor application.

Qian Y, Wang C, Xu R, Wang J, Chen Q, Zhu Z J Nanobiotechnology. 2025; 23(1):135.

PMID: 39987136 PMC: 11847370. DOI: 10.1186/s12951-025-03220-5.


Enhancing antitumour immunity with photodynamic therapy.

Selbo P, Korbelik M Photochem Photobiol Sci. 2025; 24(2):227-234.

PMID: 39971873 DOI: 10.1007/s43630-025-00690-2.


Chlorin e6: a promising photosensitizer of anti-tumor and anti-inflammatory effects in PDT.

Yu H, Huang Z, Wu J, Zhao Z, Hua Y, Yang Y Nanomedicine (Lond). 2025; 20(4):389-400.

PMID: 39877963 PMC: 11812356. DOI: 10.1080/17435889.2025.2456450.


Tailored biomimetic nanoreactor improves glioma chemodynamic treatment via triple glutathione depletion and prompt acidity elevation.

Wen Y, Qiu Q, Feng F, Zhu Y, Zhang J, Sun Z Mater Today Bio. 2025; 30:101447.

PMID: 39866788 PMC: 11762625. DOI: 10.1016/j.mtbio.2025.101447.